October 2022 Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics optimized approach of combining the data derived from steered molecular dynamics simulations and the Bell-Evans

Chris Cargill appointed as President and Chief Executive Officer • Dr.

success Sosei and PharmEnable extend neurological disease drugs hunt Sosei Heptares’ President & CEO Chris

GPCR Podcast << Back to podcast list Chris Langmead Chris Langmead is Professor, Deputy Director, and Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience

Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

Chris de Graaf September 14, 2021 at 12:00:00 PM Learn More >> Designer G protein-coupled receptors as